{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:07:57Z","timestamp":1776132477589,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2008,3,28]],"date-time":"2008-03-28T00:00:00Z","timestamp":1206662400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00105-008-1494-2","type":"journal-article","created":{"date-parts":[[2008,3,26]],"date-time":"2008-03-26T17:13:03Z","timestamp":1206551583000},"page":"917-921","source":"Crossref","is-referenced-by-count":1,"title":["Akrale Nekrosen bei metastasiertem Ovarialkarzinom","Acral necrosis in metastatic ovarian carcinoma"],"prefix":"10.1007","volume":"59","author":[{"given":"M.J.","family":"Behne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Hauswirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Menz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Br\u00fcllke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcllerleile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Moll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,3,28]]},"reference":[{"key":"1494_CR1","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1159\/000013525","volume":"19","author":"Lhotta","year":"1999","unstructured":"Lhotta K et al. (1999) Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy. Am J Nephrol 19: 590\u2013593","journal-title":"Am J Nephrol"},{"key":"1494_CR2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1096-8652(199804)57:4<293::AID-AJH5>3.0.CO;2-P","volume":"57","author":"Chow","year":"1998","unstructured":"Chow TW et al. (1998) Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Am J Hematol 57: 293\u2013302","journal-title":"Am J Hematol"},{"key":"1494_CR3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0049-3848(85)90180-X","volume":"38","author":"Asada","year":"1985","unstructured":"Asada Y et al. (1985) Immunohistochemistry of vascular lesion in thrombotic thrombocytopenic purpura, with special reference to factor VIII related antigen. Thromb Res 38: 469\u2013479","journal-title":"Thromb Res"},{"key":"1494_CR4","first-page":"369","volume":"6","author":"Saif","year":"2005","unstructured":"Saif MW, McGee PJ (2005) Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. JOP 6: 369\u2013374","journal-title":"JOP"},{"key":"1494_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.ki.5001535","volume":"70","author":"Tsai","year":"2006","unstructured":"Tsai HM (2006) The molecular biology of thrombotic microangiopathy. Kidney Int 70: 16\u201323","journal-title":"Kidney Int"},{"key":"1494_CR6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pbc.20658","volume":"46","author":"Haberichter","year":"2006","unstructured":"Haberichter SL, Shi Q, Montgomery RR (2006) Regulated release of VWF and FVIII and the biologic implications. Pediatr Blood Cancer 46: 547\u2013553","journal-title":"Pediatr Blood Cancer"},{"key":"1494_CR7","first-page":"21","volume":"24","author":"Moschcowitz","year":"1924","unstructured":"Moschcowitz E (1924) Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease. Proc NY Pathol Soc 24: 21\u201324","journal-title":"Proc NY Pathol Soc"},{"key":"1494_CR8","doi-asserted-by":"crossref","unstructured":"Sadler JE et al. (2004) Recent advances in thrombotic thrombocytopenic purpura. Hematology (Am Soc Hematol Educ Program) 1: 407\u2013423","DOI":"10.1182\/asheducation-2004.1.407"},{"key":"1494_CR9","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","volume":"21","author":"Izzedine","year":"2006","unstructured":"Izzedine H et al. (2006) Gemcitabine-induced thrombotic microangiopathy: a systematic review. Nephrol Dial Transplant 21: 3038\u20133045","journal-title":"Nephrol Dial Transplant"},{"key":"1494_CR10","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/PL00002214","volume":"96","author":"Chemnitz","year":"2001","unstructured":"Chemnitz J et al. (2001) Thrombotisch-thrombozytopenische Purpura (Moschcowitz-Syndrom). Med Klin 96: 343\u2013350","journal-title":"Med Klin"},{"key":"1494_CR11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bmj.3.5559.208","volume":"3","author":"Hawley","year":"1967","unstructured":"Hawley PR, Johnston AW, Rankin JT (1967) Association between digital ischaemia and malignant disease. BMJ 3: 208\u2013212","journal-title":"BMJ"},{"key":"1494_CR12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00000658-198707000-00010","volume":"206","author":"Taylor","year":"1987","unstructured":"Taylor LM Jr et al. (1987) Digital ischemia as a manifestation of malignancy. Ann Surg 206: 62\u201368","journal-title":"Ann Surg"},{"key":"1494_CR13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s001050051062","volume":"50","author":"Mahler","year":"1999","unstructured":"Mahler V et al. (1999) Digitale Isch\u00e4mie als Paraneoplasie bei metastasierendem Adenokarzinom des Endometrium uteri. Hautarzt 50: 748\u2013752","journal-title":"Hautarzt"},{"key":"1494_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10006-002-0399-y","volume":"6","author":"Buch","year":"2002","unstructured":"Buch RS, Geisbusch R, Kunkel M (2002) Akrale Isch\u00e4mie als seltene Paraneoplasie in der terminalen Erkrankungsphase eines Mundbodenkarzinoms. Mund Kiefer Gesichtschir 6: 331\u2013335","journal-title":"Mund Kiefer Gesichtschir"},{"key":"1494_CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4065\/71.3.253","volume":"71","author":"Chow","year":"1996","unstructured":"Chow SF, McKenna CH (1996) Ovarian cancer and gangrene of the digits: case report and review of the literature. Mayo Clin Proc 71: 253\u2013258","journal-title":"Mayo Clin Proc"},{"key":"1494_CR16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000018235","volume":"199","author":"Legrain","year":"1999","unstructured":"Legrain S, Raguin G, Piette JC (1999) Digital necrosis revealing ovarian cancer. Dermatology 199: 183\u2013184","journal-title":"Dermatology"},{"key":"1494_CR17","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2230.1996.tb00130.x","volume":"21","author":"Maurice","year":"1996","unstructured":"Maurice PD (1996) Ovarian carcinoma and digital ischaemia. Clin Exp Dermatol 21: 381\u2013382","journal-title":"Clin Exp Dermatol"},{"key":"1494_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1177\/1060028089023007-810","volume":"23","author":"Fields","year":"1989","unstructured":"Fields SM, Lindley CM (1989) Thrombotic microangiopathy associated with chemotherapy: case report and review of the literature. Dicp 23: 582\u2013588","journal-title":"Dicp"},{"key":"1494_CR19","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/(SICI)1097-0142(19990501)85:9<2023::AID-CNCR21>3.0.CO;2-2","volume":"85","author":"Fung","year":"1999","unstructured":"Fung MC et al. (1999) A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer 85: 2023\u20132032","journal-title":"Cancer"},{"key":"1494_CR20","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jnci\/86.20.1530","volume":"86","author":"Lund","year":"1994","unstructured":"Lund B et al. (1994) Phase II study of gemcitabine (2\u2019,2\u2019-difluorodeoxycytidine) in previously treated ovarian cancer patients. J Natl Cancer Inst 86: 1530\u20131533","journal-title":"J Natl Cancer Inst"},{"key":"1494_CR21","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0090-8258(03)00340-8","volume":"90","author":"Fowler","year":"2003","unstructured":"Fowler WC Jr, Van Le L (2003) Gemcitabine as a single-agent treatment for ovarian cancer. Gynecol Oncol 90: S21\u2013S23","journal-title":"Gynecol Oncol"},{"key":"1494_CR22","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0305-7372(05)80006-4","volume":"Rev","author":"Poveda","year":"2005","unstructured":"Poveda A (2005) Gemcitabine in patients with ovarian cancer. Cancer Treat Rev (Suppl 4) 31: S29\u2013S37","journal-title":"Cancer Treat"},{"key":"1494_CR23","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1046\/j.1365-2141.2001.02795.x","volume":"113","author":"Dumontet","year":"2001","unstructured":"Dumontet C et al. (2001) Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin\u2019s lymphoma. Br J Haematol 113: 772\u2013778","journal-title":"Br J Haematol"},{"key":"1494_CR24","unstructured":"Beck T (2000) Gemcitabin. In: Fricke U, Klaus W (Hrsg) Neue Arzneimittel. Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, S\u00a0525\u2013541"},{"key":"1494_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0399-8320(06)73184-0","volume":"30","author":"Desrame","year":"2006","unstructured":"Desrame J et al. (2006) La fr\u00e9quence du syndrome h\u00e9molytique et ur\u00e9mique secondaire \u00e0 la gemcitabine, est-elle sous-estim\u00e9e? Int\u00e9r\u00eat d\u2019un d\u00e9pistage syst\u00e9matique. Gastroenterol Clin Biol 30: 332\u2013334","journal-title":"Gastroenterol Clin Biol"},{"key":"1494_CR26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/00365517809104884","volume":"38","author":"Olsen","year":"1978","unstructured":"Olsen N, Nielsen SL (1978) Prevalence of primary Raynaud phenomena in young females. Scand J Clin Lab Invest 38: 761\u2013764","journal-title":"Scand J Clin Lab Invest"},{"key":"1494_CR27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00105-006-1192-x","volume":"57","author":"Sunderkotter","year":"2006","unstructured":"Sunderkotter C, Riemekasten G (2006) Raynaud-Ph\u00e4nomen in der Dermatologie. Teil\u00a01: Pathophysiologie und Diagnostik. Hautarzt 57: 819\u2013828; quiz 829","journal-title":"Hautarzt"},{"key":"1494_CR28","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0895-4356(90)90101-T","volume":"43","author":"Weinrich","year":"1990","unstructured":"Weinrich MC et al. (1990) Prevalence of Raynaud phenomenon in the adult population of South Carolina. J Clin Epidemiol 43: 1343\u20131349","journal-title":"J Clin Epidemiol"},{"key":"1494_CR29","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/ard.56.4.224","volume":"56","author":"Wright","year":"1997","unstructured":"Wright GD et al. (1997) Digital necrosis with Ogilvie\u2019s syndrome. Ann Rheum Dis 56: 224\u2013225","journal-title":"Ann Rheum Dis"},{"key":"1494_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s003840050043","volume":"11","author":"Paw","year":"1996","unstructured":"Paw P, Dharan SM, Sackier JM (1996) Digital ischemia and occult malignancy. Int J Colorectal Dis 11: 196\u2013197","journal-title":"Int J Colorectal Dis"},{"key":"1494_CR31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF02231545","volume":"12","author":"Taillan","year":"1993","unstructured":"Taillan B et al. (1993) Paraneoplastic Raynaud\u2019s phenomenon. Clin Rheumatol 12: 281\u2013282","journal-title":"Clin Rheumatol"},{"key":"1494_CR32","unstructured":"M\u00fcller-Ladner U (2006) Raynaud-Syndrom und akrale Isch\u00e4miesyndrome. Uni-Med Science. Uni-Med, Bremen"},{"key":"1494_CR33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.rdc.2005.04.006","volume":"31","author":"Grader-Beck","year":"2005","unstructured":"Grader-Beck T, Wigley FM (2005) Raynaud\u2019s phenomenon in mixed connective tissue disease. Rheum Dis Clin North Am 31: 465\u2013481, vi","journal-title":"Rheum Dis Clin North Am"},{"key":"1494_CR34","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"Mayes","year":"2003","unstructured":"Mayes MD et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48: 2246\u20132255","journal-title":"Arthritis Rheum"},{"key":"1494_CR35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/RHU.0b013e318124a89e","volume":"13","author":"Mendoza","year":"2007","unstructured":"Mendoza F, Derk CT (2007) Systemic sclerosis mortality in the United States: 1999\u20132002 implications for patient care. J Clin Rheumatol 13: 187\u2013192","journal-title":"J Clin Rheumatol"},{"key":"1494_CR36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/art.1780280114","volume":"28","author":"Gerbracht","year":"1985","unstructured":"Gerbracht DD et al. (1985) Evolution of primary Raynaud\u2019s phenomenon (Raynaud\u2019s disease) to connective tissue disease. Arthritis Rheum 28: 87\u201392","journal-title":"Arthritis Rheum"},{"key":"1494_CR37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000247924","volume":"181","author":"Takehara","year":"1990","unstructured":"Takehara K et al. (1990) Longitudinal study of patients with anticentromere antibody. Dermatologica 181: 202\u2013206","journal-title":"Dermatologica"},{"key":"1494_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0889-857X(21)01038-3","volume":"16","author":"Kallenberg","year":"1990","unstructured":"Kallenberg CG (1990) Early detection of connective tissue disease in patients with Raynaud\u2019s phenomenon. Rheum Dis Clin North Am 16: 11\u201330","journal-title":"Rheum Dis Clin North Am"},{"key":"1494_CR39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.62.8.728","volume":"62","author":"Hill","year":"2003","unstructured":"Hill CL et al. (2003) Risk of cancer in patients with scleroderma: a population based cohort study. Ann Rheum Dis 62: 728\u2013731","journal-title":"Ann Rheum Dis"},{"key":"1494_CR40","first-page":"296","volume":"12","author":"Wenzel","year":"2002","unstructured":"Wenzel J (2002) Scleroderma and malignancy. Mechanisms of interrelationship. Eur J Dermatol 12: 296\u2013300","journal-title":"Eur J Dermatol"},{"key":"1494_CR41","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jaad.2001.07.001","volume":"Dermatol","author":"Bessis","year":"2004","unstructured":"Bessis D et al. (2004) Gemcitabine-associated scleroderma-like changes of the lower extremities. J Am Acad Dermatol (Suppl 2) 51: S73\u2013S76","journal-title":"J Am Acad"},{"key":"1494_CR42","first-page":"2144","volume":"32","author":"Dellavance","year":"2005","unstructured":"Dellavance A et al. (2005) The clinical spectrum of antinuclear antibodies associated with the nuclear dense fine speckled immunofluorescence pattern. J Rheumatol 32: 2144\u20132149","journal-title":"J Rheumatol"},{"key":"1494_CR43","unstructured":"Idel H, Bunke R, Seemayer N (1978) Antinukle\u00e4re Antik\u00f6rper (ANA) bei Tumorkranken: H\u00e4ufigkeit und immunologische Charakterisierung. Zentralbl Bakteriol [B] 167: 253\u2013261"},{"key":"1494_CR44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000233517","volume":"74","author":"Silburn","year":"1984","unstructured":"Silburn PA et al. (1984) Immune complexes in ovarian cancer: association between IgM class complexes and antinuclear autoantibodies in ascitic fluid. Int Arch Allergy Appl Immunol 74: 63\u201366","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"1494_CR45","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-101-6-798","volume":"101","author":"Lokich","year":"1984","unstructured":"Lokich JJ, Moore C (1984) Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 101: 798\u2013799","journal-title":"Ann Intern Med"},{"key":"1494_CR46","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.1998.16.2.808","volume":"16","author":"Rosner","year":"1998","unstructured":"Rosner F (1998) Hand-foot syndrome in sickle cell disease. J Clin Oncol 16: 808\u2013809","journal-title":"J Clin Oncol"},{"key":"1494_CR47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00128071-200001040-00004","volume":"1","author":"Nagore","year":"2000","unstructured":"Nagore E, Insa A, Sanmartin O (2000) Antineoplastic therapy-induced palmar plantar erythrodysesthesia (\u201ahand-foot\u2018) syndrome. Incidence, recognition and management. Am J Clin Dermatol 1: 225\u2013234","journal-title":"Am J Clin Dermatol"},{"key":"1494_CR48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2005.04.018","volume":"98","author":"Ferrandina","year":"2005","unstructured":"Ferrandina G et al. (2005) Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival. Gynecol Oncol 98: 267\u2013273","journal-title":"Gynecol Oncol"},{"key":"1494_CR49","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/01.coc.0000251223.98193.f4","volume":"30","author":"El-Rayes","year":"2007","unstructured":"El-Rayes BF et al. (2007) A phase I study of gemcitabine and uracil-ftorfar (UFT)\/leucovorin. Am J Clin Oncol 30: 101\u2013105","journal-title":"Am J Clin Oncol"},{"key":"1494_CR50","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cncr.20795","volume":"103","author":"Rini","year":"2005","unstructured":"Rini BI, Weinberg V, Small EJ (2005) A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma. Cancer 103: 553\u2013558","journal-title":"Cancer"},{"key":"1494_CR51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00105-006-1218-4","volume":"57","author":"Sunderkotter","year":"2006","unstructured":"Sunderkotter C, Riemekasten G (2006) Raynaud-Ph\u00e4nomen in der Dermatologie: Teil\u00a02: Therapie. Hautarzt 57: 927\u2013938; quiz 941","journal-title":"Hautarzt"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1494-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-008-1494-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-008-1494-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T14:29:35Z","timestamp":1630938575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-008-1494-2"}},"subtitle":["Ausdruck eines singul\u00e4ren Moschkowitz-Syndroms unter Gemcitabin-Chemotherapie","A single episode of Moschowitz syndrome during gemcitabine chemotherapy"],"short-title":[],"issued":{"date-parts":[[2008,3,28]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["1494"],"URL":"https:\/\/doi.org\/10.1007\/s00105-008-1494-2","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,28]]}}}